Teva Pharmaceutical Industries' specialty medicines revenues breakdown 2022-2024

Published by
Matej Mikulic,
Feb 12, 2025

This statistic shows the specialty medicines revenues breakdown of pharmaceutical company Teva from 2022 to 2024, by product. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. In 2024, top product Austedo generated revenues of around 1.64 billion U.S. dollars.

Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2024 (in million U.S. dollars)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2025

Region

Worldwide, Israel

Survey time period

2022 to 2024

Supplementary notes

* Revenue only for the United States.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Teva "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Teva

Global positioning

5

Key figures

5

Competitors

4

Costs and expenses

3

Regions and segments

3

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

TevaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.